Cargando…

Effect of a pharmacist managed smoking cessation clinic on quit rates

OBJECTIVE: The purpose of this study was to quantify quit rates, determine factors predicting success, and analyze patients’ perceptions at 3 months after participation in the pharmacist-managed Smoking Cessation Group Clinic. METHODS: This was a prospective, single group study that was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Philbrick, Ann M., Newkirk, Erin N., Farris, Karen B., McDanel, Deanna L., Horner, Kathleen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139046/
https://www.ncbi.nlm.nih.gov/pubmed/25143792
_version_ 1782331315199148032
author Philbrick, Ann M.
Newkirk, Erin N.
Farris, Karen B.
McDanel, Deanna L.
Horner, Kathleen E.
author_facet Philbrick, Ann M.
Newkirk, Erin N.
Farris, Karen B.
McDanel, Deanna L.
Horner, Kathleen E.
author_sort Philbrick, Ann M.
collection PubMed
description OBJECTIVE: The purpose of this study was to quantify quit rates, determine factors predicting success, and analyze patients’ perceptions at 3 months after participation in the pharmacist-managed Smoking Cessation Group Clinic. METHODS: This was a prospective, single group study that was conducted in patients that had participated in the Smoking Cessation Group Clinic at the University of Iowa Hospitals and Clinics. Clinic participants received structured group counseling covering various topics associated with cessation. Varenicline, bupropion and nicotine replacement therapy were used as smoking cessation aids and selection was based on patient preference and absence of contraindications. The primary outcome of this trial was smoking status at 3 months. The patients were contacted by telephone at 3, and 6 months after the start of the clinic and asked about current smoking status. At 3 months, patients were asked to rate on a Likert scale of 1 to 5 (1=not helpful; 5=very helpful) their perceptions of individual aspects of the clinic and on a scale of 1 to 10 (1=not helpful; 10=very helpful) how they perceived their cessation aid. RESULTS: From February 2007 to January 2008, 21 patients enrolled in the intent-to-treat follow up study. Analysis of data was completed in August 2008. At 3 and 6 months, 47.6% and 52.4%, of patients reported being smoke-free, respectively. At 3 months, factors consistent with success included having more previous quit attempts and type of cessation aid used. These endpoints continued to be significant at 6 months, in addition to attending more clinic sessions, and type of insurance (favoring private insurance). Patients who quit smoking rated their cessation aid as more helpful than those who did not quit smoking (8.56; SD=0.88 verses 6.71; SD=2.81, respectively; p=0.14). The aspect of the clinic most helpful to patients was group interaction (4.53; SD=0.77). CONCLUSION: This study demonstrates that pharmacists can play a vital role with smoking cessation in a group setting. Group setting patient counseling can be an effective tool for pharmacists to reach more people within the same time frame as individual counseling.
format Online
Article
Text
id pubmed-4139046
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41390462014-08-20 Effect of a pharmacist managed smoking cessation clinic on quit rates Philbrick, Ann M. Newkirk, Erin N. Farris, Karen B. McDanel, Deanna L. Horner, Kathleen E. Pharm Pract (Granada) Original Research OBJECTIVE: The purpose of this study was to quantify quit rates, determine factors predicting success, and analyze patients’ perceptions at 3 months after participation in the pharmacist-managed Smoking Cessation Group Clinic. METHODS: This was a prospective, single group study that was conducted in patients that had participated in the Smoking Cessation Group Clinic at the University of Iowa Hospitals and Clinics. Clinic participants received structured group counseling covering various topics associated with cessation. Varenicline, bupropion and nicotine replacement therapy were used as smoking cessation aids and selection was based on patient preference and absence of contraindications. The primary outcome of this trial was smoking status at 3 months. The patients were contacted by telephone at 3, and 6 months after the start of the clinic and asked about current smoking status. At 3 months, patients were asked to rate on a Likert scale of 1 to 5 (1=not helpful; 5=very helpful) their perceptions of individual aspects of the clinic and on a scale of 1 to 10 (1=not helpful; 10=very helpful) how they perceived their cessation aid. RESULTS: From February 2007 to January 2008, 21 patients enrolled in the intent-to-treat follow up study. Analysis of data was completed in August 2008. At 3 and 6 months, 47.6% and 52.4%, of patients reported being smoke-free, respectively. At 3 months, factors consistent with success included having more previous quit attempts and type of cessation aid used. These endpoints continued to be significant at 6 months, in addition to attending more clinic sessions, and type of insurance (favoring private insurance). Patients who quit smoking rated their cessation aid as more helpful than those who did not quit smoking (8.56; SD=0.88 verses 6.71; SD=2.81, respectively; p=0.14). The aspect of the clinic most helpful to patients was group interaction (4.53; SD=0.77). CONCLUSION: This study demonstrates that pharmacists can play a vital role with smoking cessation in a group setting. Group setting patient counseling can be an effective tool for pharmacists to reach more people within the same time frame as individual counseling. Centro de Investigaciones y Publicaciones Farmaceuticas 2009 2009-03-15 /pmc/articles/PMC4139046/ /pubmed/25143792 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Philbrick, Ann M.
Newkirk, Erin N.
Farris, Karen B.
McDanel, Deanna L.
Horner, Kathleen E.
Effect of a pharmacist managed smoking cessation clinic on quit rates
title Effect of a pharmacist managed smoking cessation clinic on quit rates
title_full Effect of a pharmacist managed smoking cessation clinic on quit rates
title_fullStr Effect of a pharmacist managed smoking cessation clinic on quit rates
title_full_unstemmed Effect of a pharmacist managed smoking cessation clinic on quit rates
title_short Effect of a pharmacist managed smoking cessation clinic on quit rates
title_sort effect of a pharmacist managed smoking cessation clinic on quit rates
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139046/
https://www.ncbi.nlm.nih.gov/pubmed/25143792
work_keys_str_mv AT philbrickannm effectofapharmacistmanagedsmokingcessationcliniconquitrates
AT newkirkerinn effectofapharmacistmanagedsmokingcessationcliniconquitrates
AT farriskarenb effectofapharmacistmanagedsmokingcessationcliniconquitrates
AT mcdaneldeannal effectofapharmacistmanagedsmokingcessationcliniconquitrates
AT hornerkathleene effectofapharmacistmanagedsmokingcessationcliniconquitrates